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A paradoxical response in a patient infected with tuberculosis
is generally deﬁned as the clinical or radiological worsening of
pre-existing tuberculous lesions or the development of new le-
sions in a patient who initially improves with anti-tuberculosis
therapy. It occurs in about 5% of patients with a clinical diag-
nosis of Mycobacterium tuberculosis infection. Since a rapid
and accurate diagnostic test is lacking, the diagnosis of this
paradoxical phenomenon can only be ascertained when other
differential diagnoses such as secondary infections, inadequate
anti-tuberculosis therapy as a result of drug resistance, poor
compliance, and adverse reactions due to therapy are excluded.
Clinical presentations
Paradoxical deterioration mostly occurs in patients with extra-
pulmonary and disseminated tuberculosis, like miliary tuber-
culosis and tuberculous meningitis. The median time to the
development of a paradoxical response is 60 days, ranging
from 14 to 270 days in HIV-negative patients [1]. In addition
to systemic reactions such as fever, the clinical symptoms
and signs of paradoxical deterioration can be manifested in
the initial site of infection as well as in an anatomical site other
than that of the initial presentation. The central nervous sys-
tem and the respiratory system remain the most common sites
of involvement during paradoxical deterioration reported in
the literature [1]. For the central nervous system manifesta-
tions, patients may have headache, mental confusion, focal
seizures and cranial nerve palsies. The most common presenta-
tion in the respiratory system includes the worsening or
appearance of a pleural effusion, either in the ipsilateral or
contralateral side, whereas an increase in pulmonary parenchy-
mal inﬁltration is only seen occasionally. Paradoxical re-
sponses can also occur in lymph nodes, skin, soft tissue,
bone, tendon and inside the abdomen.Peer review under responsibility of The Egyptian Society of Chest
Diseases and Tuberculosis.
Production and hosting by Elsevier
0422-7638 ª 2013 The Egyptian Society of Chest Diseases and Tuberculos
http://dx.doi.org/10.1016/j.ejcdt.2013.0Open access under CC BY-NC-ND license.Pathogenesis
The exact mechanism of this paradoxical response remains
uncertain. Immunorestitution phenomenon has been suggested
as a possible explanation. In patients with active Mycobacte-
rium tuberculosis infections, there is a biased T-helper2 immune
response as evident by an increase in the percentage of inter-
leukin-4 and interleukin-10 positive lymphocytes together with
a low percentage of interleukin-12 positive lymphocytes in the
peripheral blood, especially in those patients with tuberculin
anergy [2]. Furthermore, puriﬁed protein derivative-stimulated
production of interferon-gamma by peripheral blood mononu-
clear cells was depressed, whereas levels of transforming
growth factor-beta and interleukin-10 were increased [3]. How-
ever, when the mycobacterial load was signiﬁcantly reduced
after the initiation of anti-tuberculosis therapy, the cellular
and cytokine patterns reverse which may result in an inﬂam-
matory response leading to a paradoxical phenomenon. The
clinical severity of paradoxical deterioration is dependent on
the exactness and appropriateness of immune recovery. An
overwhelming immunorestitution may produce excessive
immunopathological damage at the tissue level [4]. In HIV po-
sitive patients, a paradoxical response may occur during rever-
sal of the immunosuppressive state when highly active
antiretroviral therapy (HAART) is coadministrated within
2 months of anti-tuberculosis treatment. This phenomenon ap-
pears more frequently in those patients with a signiﬁcant
reduction in HIV viral load and an increase in CD4-lympho-
cyte count after HAART and called immune reconstitution
inﬂammatory syndrome [5].
Risk factors
In both HIV-negative and HIV-positive patients, paradoxical
deterioration more frequently occurs in patients with extra-
pulmonary involvement and is associated with a lower lym-
phocyte counts at the baseline [6,7]. There is no difference
in age, sex, and underlying co-morbidity in patients with or
without a paradoxical response. At the time of paradoxical
deterioration, a concomitant increase in the lymphocyte
count and conversion of the tuberculin skin test is observed
in a minority of patients [1,8]. However, whether interval
lymphocyte counts and tuberculin skin tests can be used to
predict the development of a paradoxical response requires
further investigation.is. Production and hosting by Elsevier B.V.
9.004
2 EditorialDiagnosis
The diagnosis of paradoxical phenomenon is made by exclu-
sion. Investigations should be performed to rule out other
causes of clinical deterioration during antituberculosis therapy
such as secondary infections, inadequate anti-tuberculosis
therapy as a result of drug resistance, poor compliance, and
adverse reactions due to therapy. Therefore, the diagnosis of
a paradoxical response may not be difﬁcult when the clinical
deterioration occurs before the results of drug susceptibility
are available.
Management
Patients with non-severe forms of paradoxical phenomenon
such as recurrence of fever, enlargement of superﬁcial lymph
nodes, and increased pulmonary inﬁltrates or pleural effusion
do not require speciﬁc treatment. Patients should be reassured
and the antituberculosis treatment should be continued. How-
ever, severe clinical deterioration may occasionally occur in
patients with enlargement of intracranial tuberculomas with
obstructive hydrocephalus, massive pleural effusions compro-
mising respiratory function, and the development of deep
seated abscesses leading to a pressure effect especially inside
the abdomen or spine [1]. The uses of immunomodulators such
as steroids along with surgical interventions such as insertion
of a ventriculo-peritoneal shunt, thoracocentesis, and drainage
of abscesses should be considered. A short course and tailing
dose of steroids in the management of paradoxical deteriora-
tion appears to be safe [1]. Most patients will recover unevent-
fully with either conservative treatment or a combination of
medical and surgical management. Only a few cases with cen-
tral nervous system involvement result in residual neurological
deﬁcits.
Conclusion
Paradoxical response during anti-tuberculosis therapy is not
an uncommon phenomenon. A better understanding of the
clinical presentation and pathogenesis can facilitate a diag-
nosis so that appropriate management can be made
accordingly.Conﬂict of interest
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